In 2015, Bandekar and co-workers designed and evaluated PEGylated liposomal NPs, which were loaded with 225Ac and functionalized with mouse anti-human PSMA J591 antibody or with A10 PSMA aptamer for the PSMA-targeted radiotherapy of PCa (Figure 14) [34]. Here, FOLH1 is linked to posterior cortical atrophy.